The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials

OBJECTIVE: DC-CIK therapy included DC-CIK cells and Ag-DC-CIK cells. To further confirm whether DC-CIK reconstructs the antitumor immunity and improves the tumor responses and reveals its optimal usage and combination with chemotherapy, we systematically reevaluated all the related studies. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zheng, Wang, Cheng-qiong, Zhou, Ming-hua, Li, Na-na, Sun, Yong-ping, Wang, Yu-zhi, Liu, Shi-yu, Yu, Hong-song, Li, Cheng-wen, Zeng, Xian-tao, Chen, Ling, Yao, Xin-sheng, Feng, Ji-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311820/
https://www.ncbi.nlm.nih.gov/pubmed/30648123
http://dx.doi.org/10.1155/2018/9081938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311820/
https://www.ncbi.nlm.nih.gov/pubmed/30648123
http://dx.doi.org/10.1155/2018/9081938

Ejemplares similares